1. Home
  2. MIRM vs ABG Comparison

MIRM vs ABG Comparison

Compare MIRM & ABG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$91.35

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Logo Asbury Automotive Group Inc

ABG

Asbury Automotive Group Inc

HOLD

Current Price

$243.54

Market Cap

4.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIRM
ABG
Founded
2018
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail-Auto Dealers and Gas Stations
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
4.5B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
MIRM
ABG
Price
$91.35
$243.54
Analyst Decision
Strong Buy
Hold
Analyst Count
11
7
Target Price
$97.55
$261.29
AVG Volume (30 Days)
836.6K
176.1K
Earning Date
02-25-2026
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.57
EPS
N/A
28.52
Revenue
$471,794,000.00
$17,827,000,000.00
Revenue This Year
$54.25
$6.67
Revenue Next Year
$21.09
$7.62
P/E Ratio
N/A
$8.58
Revenue Growth
53.66
8.07
52 Week Low
$36.88
$201.68
52 Week High
$93.70
$312.56

Technical Indicators

Market Signals
Indicator
MIRM
ABG
Relative Strength Index (RSI) 71.95 53.19
Support Level $85.98 $237.38
Resistance Level $93.70 $252.13
Average True Range (ATR) 3.83 7.31
MACD 0.95 0.12
Stochastic Oscillator 87.40 58.37

Price Performance

Historical Comparison
MIRM
ABG

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

About ABG Asbury Automotive Group Inc

Asbury Automotive Group is a regional collection of automobile dealerships that went public in March 2002. The company operates 152 new-vehicle stores and 37 collision centers. Over 70% of new-vehicle revenue is from luxury and import brands. Asbury also offers third-party financing and insurance products and its own F&I products via Total Care Auto. Asbury operates in 14 states (mostly Texas, the West, the Mid-Atlantic, and the Southeast). Asbury store brands include McDavid and Park Place in Texas, Koons in the Washington, D.C. area, and the Larry H. Miller brand in the Western US. Asbury generated $17.2 billion of revenue in 2024 and is based in the Atlanta area. The firm targets at least $30 billion of revenue sometime around 2030.

Share on Social Networks: